-74%

est. 2Y upside i

HealthcareSeries D+

Connecting stakeholders across the healthcare ecosystem.

Rank

#4241

Sector

Healthcare Data & Analytics

Est. Liquidity

~4Y

Data Quality

Data: Medium

H1's severe preference stack ($321M on $773M = 41.5%) is the biggest red flag. $35M ARR at $773M is 22x, and current healthcare SaaS multiples suggest $525-630M fair value.

Last updated: March 21, 2026

Bull (10%)+80%

Acquisitions create unified platform, ARR to $100M+, strategic acquirer at $1.4B+.

Base (55%)-20%

Integration consumes bandwidth, ARR grows to $50-60M, flat valuation $600-780M.

Bear (35%)-65%

Integration churn, incumbents crowd out, distressed sale $400-500M.

Est. time to liquidity~3.5 years

Preference Stack Risk

severe

Funding Intensity

42%

$321M against $773M (41.5%).

Dilution Risk

high

Two acquisitions plus growth need more capital.

Secondary Liquidity

limited

No active tender offer program.

Questions to Ask at the Interview

Strategic questions based on H1's data — designed to show you've done your homework.

  • 1

    “How is positioning vs Definitive Healthcare and Doximity?”

  • 2

    “Integration roadmap for Ribbon + Veda?”

  • 3

    “Secondary liquidity or tender program?”

Community

Valuation Sentiment

Our model estimates -74% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.